Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.383
Neutral
RSI(14)
46.321
Neutral
STOCH(KDJ)(9,3,3)
20.698
Sell
ATR(14)
2.883
High Vlolatility
CCI(14)
-58.217
Neutral
Williams %R
71.792
Sell
TRIX(12,20)
-0.046
Sell
StochRSI(14)
0.000
Oversold
DaVita Inc
DVA137.350USD
+1.790+1.32%
Market hours （ET）Quotes delayed by 15 min
10.19BMarket Cap
12.19P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-04Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
10
analysts
Hold
Current Rating
153.540
Target Price
+12.92%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 67.08.
Undervalued
The company’s latest PE is 13.05, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 73.92M shares, decreasing 8.01% quarter-over-quarter.
Held by Warren Buffett
Star Investor Warren Buffett holds 32.16M shares of this stock.
Financial Health
Currency: USD Updated：2025-09-04The company's current financial score is 7.15, which is equal to the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 3.22B, representing a year-over-year increase of 4.98%, while its net profit experienced a year-over-year increase of 32.02%.
Score
Financials
6.59
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.11
Operational Efficiency
7.53
Growth Potential
7.36
Shareholder Returns
7.17
Company Valuation
Currency: USD Updated：2025-09-04The company’s current valuation score is 1.20, which is lower than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 13.24, which is 5.21% below the recent high of 13.93 and -0.87% above the recent low of 13.36.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 73/280
No Data
Earnings Forecast
Currency: USD Updated：2025-09-04The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for DaVita Inc is 149.16, with a high of 186.00 and a low of 137.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
10
analysts
Hold
Current Rating
153.540
Target Price
+12.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
69
Total
7
Median
8
Average
Company name
Ratings
Analysts
DaVita Inc
DVA
10
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Natera Inc
NTRA
22
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-04The company’s current price momentum score is 9.00, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 146.08 and the support level at 127.56, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
136.454
Buy
MA10
137.378
Sell
MA20
135.196
Buy
MA50
139.475
Sell
MA100
139.856
Sell
MA200
148.269
Sell
Institutional Confidence
Currency: USD Updated：2025-09-04The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 100.87%, representing a quarter-over-quarter increase of 1.09%. The largest institutional shareholder is Warren Buffett, holding a total of 32.16M shares, representing 44.98% of shares outstanding, with 0.36% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Weschler (R Ted)
State Street Global Advisors (US)
Geode Capital Management, L.L.C.
Gates Capital Management, Inc.
Dimensional Fund Advisors, L.P.
LSV Asset Management
1
2
Risk Assessment
Currency: USD Updated：2025-09-04The company's beta value is 1.13. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.14
VaR
+2.87%
240-Day Maximum Drawdown
+28.00%
240-Day Volatility
+33.25%
Return
Best Daily Return
60 days
+4.75%
120 days
+6.21%
5 years
+12.90%
Worst Daily Return
60 days
-9.04%
120 days
-9.04%
5 years
-27.09%
Sharpe Ratio
60 days
-0.07
120 days
-0.20
5 years
+0.32
Risk Assessment
Maximum Drawdown
240 days
+28.00%
3 years
+35.04%
5 years
+51.10%
Return-to-Drawdown Ratio
240 days
-0.60
3 years
+0.47
5 years
+0.09
Skewness
240 days
-1.43
3 years
-2.76
5 years
-2.37
Volatility
Realised Volatility
240 days
+33.25%
5 years
+34.14%
Standardised True Range
240 days
+3.01%
5 years
+2.28%
Downside Risk-Adjusted Return
120 days
-24.94%
240 days
-24.94%
Maximum Daily Upside Volatility
60 days
+19.92%
Maximum Daily Downside Volatility
60 days
+24.62%
Liquidity
Average Turnover Rate
60 days
+1.07%
120 days
+1.07%
5 years
--
Turnover Deviation
20 days
+9.86%
60 days
+0.19%
120 days
+0.87%
Peer Comparison
Currency: USD Updated：2025-09-04DaVita Inc
DVA
6.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.90 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
MMSI
7.80 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
THC
7.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
7.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
7.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
